1. Home
  2. ETON vs TRVG Comparison

ETON vs TRVG Comparison

Compare ETON & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • TRVG
  • Stock Information
  • Founded
  • ETON 2017
  • TRVG 2005
  • Country
  • ETON United States
  • TRVG Germany
  • Employees
  • ETON N/A
  • TRVG N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • TRVG EDP Services
  • Sector
  • ETON Health Care
  • TRVG Technology
  • Exchange
  • ETON Nasdaq
  • TRVG Nasdaq
  • Market Cap
  • ETON 329.8M
  • TRVG 306.5M
  • IPO Year
  • ETON 2018
  • TRVG N/A
  • Fundamental
  • Price
  • ETON $14.22
  • TRVG $5.40
  • Analyst Decision
  • ETON Strong Buy
  • TRVG Hold
  • Analyst Count
  • ETON 3
  • TRVG 5
  • Target Price
  • ETON $27.67
  • TRVG $2.94
  • AVG Volume (30 Days)
  • ETON 248.9K
  • TRVG 109.1K
  • Earning Date
  • ETON 03-18-2025
  • TRVG 04-29-2025
  • Dividend Yield
  • ETON N/A
  • TRVG N/A
  • EPS Growth
  • ETON N/A
  • TRVG N/A
  • EPS
  • ETON N/A
  • TRVG N/A
  • Revenue
  • ETON $39,011,000.00
  • TRVG $477,118,749.00
  • Revenue This Year
  • ETON $107.69
  • TRVG $9.85
  • Revenue Next Year
  • ETON $65.50
  • TRVG $6.77
  • P/E Ratio
  • ETON N/A
  • TRVG N/A
  • Revenue Growth
  • ETON 23.29
  • TRVG N/A
  • 52 Week Low
  • ETON $3.03
  • TRVG $1.60
  • 52 Week High
  • ETON $18.41
  • TRVG $5.03
  • Technical
  • Relative Strength Index (RSI)
  • ETON 43.84
  • TRVG 75.86
  • Support Level
  • ETON $12.73
  • TRVG $3.90
  • Resistance Level
  • ETON $15.73
  • TRVG $4.92
  • Average True Range (ATR)
  • ETON 0.93
  • TRVG 0.36
  • MACD
  • ETON -0.01
  • TRVG 0.07
  • Stochastic Oscillator
  • ETON 49.67
  • TRVG 97.33

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.

Share on Social Networks: